Enabling Microbiomics- Driven Personalized Nutrition

Launched by MAYO CLINIC · Oct 23, 2024

Keywords

ClinConnect Summary

This clinical trial, titled "Enabling Microbiomics-Driven Personalized Nutrition," is focused on understanding how our diet, genetics, and gut bacteria (microbiome) can affect various digestive health issues, such as Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome (IBS), Crohn's Disease, and Celiac Disease. The researchers want to find out how these factors contribute to gastrointestinal problems and if their impact is different for different people.

To participate in this study, you need to be at least 18 years old and have a diagnosed gastrointestinal condition like those mentioned, or be a healthy individual without any digestive issues. Participants should also have a smartphone with internet access and be able to give informed consent. It’s important to note that individuals with cognitive impairments or those currently taking antibiotics cannot join the trial. If you're eligible, you'll be part of a research effort that aims to improve understanding of gut health and potentially lead to personalized dietary recommendations in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age greater than or equal to 18 years
• * Gastrointestinal patients with or without genomic sequencing results available for the following cohorts:
• • Inflammatory Bowel Disease (IBD)
• • Irritable Bowel Syndrome (IBS)
• • Crohn's Disease
• • Celiac Disease
• • Diarrhea
• • Constipation
• • Healthy age and sex matched controls with or without genomic sequencing results available
• • o Control is defined as patients without gastrointestinal disease or no symptoms at time of sampling
• • Able to provide written, informed consent
• • Participant has a smartphone device with access to internet connection
• Exclusion Criteria:
• • Patients with cognitive impairment
• • Active use of antibiotics at the time of stool collection